Be Ready for the New Combo HIV Med Biktarvy

Biktarvy (bik-TAR-vee, bictegravir/emtricitabine/tenofovir alafenamide) will be a new first-line option for HIV.

Think of it as a complete HIV regimen in one pill.

Biktarvy combines a new integrase inhibitor, bictegravir...with two nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors (NRTIs), emtricitabine and tenofovir alafenamide.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote